After treatment with BLM alone, α-SMA expression increased in a time-dependent manner compared to the levels in the corresponding controls, whereas additional treatment with msFGFR2c on day 30 reversed these changes, suggesting that msFGFR2c reverse the fibertic process induced by BLM (Fig. 4h). This evidence concerns the gene ACTA1 and Bloom syndrome.